These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9820295)

  • 1. Heads or tails in a positive faecal occult blood test.
    Itzkowitz SH
    Lancet; 1998 Nov; 352(9139):1490. PubMed ID: 9820295
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for occult faecal blood loss in a community by means of Hemoccult II slides and a tetramethylbenzidine test.
    Dybdahl JH; Haug K; Bakkevold K; Olsen KO; Vetvik K
    Scand J Gastroenterol; 1984 May; 19(3):343-9. PubMed ID: 6740209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening. Faecal occult blood tests.
    McDonald C
    Aust Fam Physician; 1985 Apr; 14(4):273, 276-7. PubMed ID: 4015528
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
    Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
    Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.
    Rockey DC; Koch J; Cello JP; Sanders LL; McQuaid K
    N Engl J Med; 1998 Jul; 339(3):153-9. PubMed ID: 9664091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of the fecal occult blood test for colorectal neoplasia.
    Winawer SJ; Fleisher M
    Gastroenterology; 1982 May; 82(5 Pt 1):986-91. PubMed ID: 7060917
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of faecal alpha-1-antitrypsin, haemoglobin and a chemical occult blood test in the detection of gastrointestinal disease.
    Moran A; Lawson N; Morrow R; Jones A; Asquith P
    Clin Chim Acta; 1993 Aug; 217(2):153-61. PubMed ID: 8261624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with haemoccult screening in Hungary. A multicenter trial.
    Siba S
    Hepatogastroenterology; 1983 Feb; 30(1):27-9. PubMed ID: 6601046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of the history and stool occult blood test in selection of patients for upper endoscopy in Zimbabwe.
    Xavier RJ; Stein CM; Kiire CF; Arrow J; Kitai I
    East Afr Med J; 1992 May; 69(5):268-71. PubMed ID: 1644046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of Fecatwin/Feca EIA; a faecal occult blood test for detecting colonic neoplasia.
    Pye G; Marks CG; Martin S; Marks V; Jackson J; Hardcastle JD
    Eur J Surg Oncol; 1989 Oct; 15(5):446-8. PubMed ID: 2792395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonoscopy vs sigmoidoscopy: new studies fuel ongoing debate.
    Schmidt C
    J Natl Cancer Inst; 2012 Sep; 104(18):1350-1. PubMed ID: 22984198
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of the study of occult fecal blood with Hemoccult II in 211 symptomatic patients controlled by total colonoscopy].
    Morini S; Manurita L; Stroppa I; Bassi O
    Minerva Med; 1984 Apr; 75(17):963-6. PubMed ID: 6728249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients.
    Hisamuddin K; Mowat NA; Phull PS
    Dig Liver Dis; 2006 Jul; 38(7):503-7. PubMed ID: 16522381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems with the investigation of a problem with faecal occult blood tests.
    Fraser CG
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):391-2; author reply 392. PubMed ID: 20511378
    [No Abstract]   [Full Text] [Related]  

  • 16. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult faecal blood loss determined by a 51Cr method and chemical tests in patients referred for colonoscopy.
    Dybdahl JH; Daae LN; Larsen S; Myren J
    Scand J Gastroenterol; 1984 Mar; 19(2):245-54. PubMed ID: 6609422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interval bowel cancers may not be detected on faecal occult blood testing.
    George AT; Aggarwal S; Fields A; Vogler M; Menon A; Dube M
    BMJ; 2014 Apr; 348():g2390. PubMed ID: 24699121
    [No Abstract]   [Full Text] [Related]  

  • 19. What do we gain from the sixth stool guaiac?
    Neuhauser D; Lewicki AM
    N Engl J Med; 1975 Jul; 293(5):226-8. PubMed ID: 1143302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bowel Cancer Screening Programme: an unusual cause of positive faecal occult bloods.
    Lidder PG; Buckley D; Pullan RD
    Gut; 2010 Apr; 59(4):480, 512. PubMed ID: 20332519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.